Biomedical Warming and Thawing Devices Market source, By Sample (Ovum/Embryo, Blood Products, Semen, Others), By Product, (Automatic, Manual), By End-use, (Hospitals, Research Laboratories, Pharmaceutical Industry, Blood Banks and Transfusion Centers, Others), By Region – Global Analysis Forecast Till 2030

Biomedical Warming and Thawing Devices market was accounted for $194.12 million in 2021 and is expected to reach $386 million by 2030, at a CAGR of 8.12% during the forecast period.

Biomedical warming and thawing units are used to thaw blood, tissue, cells, and other biological product samples. Cells and tissues can be successfully and stably preserved using cryopreservation at lower temperatures, often below freezing. Therefore, these natural products must be thawed before use. Biomedical warming and thawing devices that help keep frozen products warm and thawed are essential in these situations. Prolonged exposure to these chemicals can degrade the preserved material's living cells and other components. Biomedical warming and thawing devices reduce the risk of frozen preservative chemicals harming these objects. Biomedical warming and thawing devices are necessary to keep stored cells in a useful and viable state for use in medical treatment.

Market Dynamics:

The growth of blood banks and infusion facilities, traffic accidents and trauma cases requiring blood transfusions, and the increased popularity of in vitro fertilisation are the main factors driving the global market size for biomedical warming and thawing devices. Depending on test results, blood banks retain cryopreserved red blood cells, whole blood, platelets, and plasma for a finite amount of time. As a result, there is an increase in the need for biomedical warming and thawing systems for cryopreservation products as there are more blood banks and blood transfusion facilities. Thus, it is anticipated that this aspect will spur the development of biomedical warming and thawing devices. Moreover, as the demand for blood donation soars, the demand for warming and thawing devices at blood banks and transfusion centers is rapidly increasing.

Restraints:

The biomedical warming and thawing devices market could be harmed by worries about large batch sizes and strict regulatory requirements connected to the usage of cryopreserved and thawed biomedical products. Cryopreserved biologics have also required careful transportation, which has been facilitated by logistics and supply chain management. Supply chains were interrupted during the pandemic, which further hampered the growth of the biomedical thawing device industry. Cryopreserved stem cells, blood products, and other items could not move freely.

Key players:

• Helmer Scientific,

• Brook Life Sciences,

• Sartorius AG,

• Sarstedt AG & Co. KG,

• Boekel Scientific,

• Barkey, 

• Cytiva,

• Cardinal Health,

• and BioLife Solutions

Market Segmentation:

The Global Biomedical Warming and Thawing Devices Market, By Product Outlook,

• Automatic

• Manual

The Global Biomedical Warming and Thawing Devices Market, By Sample Outlook

• Ovum/Embryo

• Blood Products

• Semen

• Others

The Global Biomedical Warming and Thawing Devices Market, By End-use,

• Hospitals

• Research Laboratories

• Pharmaceutical Industry

• Blood Banks and Transfusion Centers

• Others

The Global Biomedical Warming and Thawing Devices Market, By Region:

• North America

  • U.S.

  • Canada

• Europe

  • Germany

  • France

  • UK

  • Spain

  • Italy

• Asia Pacific

  • China

  • Japan

  • India

  • Australia

  • South Korea

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Iran

Regional Analysis:

North America is expected to hold a major market share during the forecast period, owing to the increasing importance of cryopreservation of cell and blood products and the presence of major players manufacturing these devices in the United States. The European market is expected to expand. Increased demand for technologically advanced biomedical warming and thawing devices in countries such as UK, Germany and France and extensive research activities on blood products at a rapid pace during the forecast period.

The growth in the use of biomedical equipment, the rising awareness of cell viability, and the improvement of healthcare infrastructure in Asia Pacific's emerging economies are the key factors driving the market for biomedical warming and thawing devices during the forecast period. The biomedical warming and thawing devices in the Middle East and Africa is propelled by the region's high demand for high-quality medical equipment, as well as the quick development of medical technology and rising use of automated healthcare systems.

Scope of the Report:

User

Tab Content